Both in Pharmaceuticals
Kiniksa Pharmaceuticals International vs Praxis Precision Medicines
Over the past year KNSA returned +152.4% and PRAX returned +56.6%; their daily moves had a correlation of 0.13.
KNSA +152.4% PRAX +56.6%Growth of $1, one year, split-adjusted
| Metric | KNSA | PRAX |
|---|---|---|
| Price | $94.56 | $285.04 |
| Market cap | $7.43B | $7.96B |
| Today | +1.36% | +1.61% |
| 1 month | +22.7% | +1.7% |
| 6 months | +62.4% | −15.7% |
| Year to date | +129.2% | −3.3% |
| 1 year | +152.4% | +56.6% |
| Revenue growth (YoY) | +58.1% | — |
| Gross margin | 90.3% | — |
| Net margin | 16.6% | — |
| P/E (TTM) | 67.8× | — |
| Price / sales | 7.9× | — |
| Net cash | $462.9M | $758.6M |
| Dividend yield | — | — |
| Volatility (60d) | 54.0% | 48.6% |
| Short % of float | 9.6% | 14.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).